Literature DB >> 24664088

Fetal onset ventriculomegaly and subependymal cysts in a pyridoxine dependent epilepsy patient.

Shailly Jain-Ghai1, Navin Mishra, Cecil Hahn, Susan Blaser, Saadet Mercimek-Mahmutoglu.   

Abstract

Pyridoxine dependent epilepsy (PDE) is caused by mutations in the ALDH7A1 gene encoding α-aminoadipic semialdehyde dehydrogenase. The classic clinical presentation is neonatal seizures responsive only to pyridoxine therapy. White matter abnormalities, corpus callosum agenesis or hypoplasia, megacisterna magna, cortical dysplasia, neuronal heterotopias, intracerebral hemorrhage, and hydrocephalus in neuroimaging have been reported in patients with PDE. We report a new patient with asymmetric progressive ventriculomegaly noted on fetal sonography at 22 weeks' gestation. Postnatal brain sonography on day 1 and MRI on day 5 confirmed bilateral asymmetric ventriculomegaly caused by bilateral subependymal cysts. Intractable seizures at age 7 days initially responded to phenobarbital. Markedly elevated urinary α-aminoadipic acid semialdehyde levels and compound heterozygous mutations in the ALDH7A1 gene (c.446C>A/c.919C>T) confirmed the diagnosis of PDE caused by ALDH7A1 genetic defect. Despite the presence of structural brain malformations and subependymal cysts, PDE should always be included in the differential diagnosis of neonatal seizures that are refractory to treatment with antiepileptic drugs.

Entities:  

Keywords:  ALDHA71 deficiency; pyridoxine dependent epilepsy; subependymal cysts; ventriculomegaly

Mesh:

Year:  2014        PMID: 24664088     DOI: 10.1542/peds.2013-1230

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

1.  Abnormal Injury Response in Spontaneous Mild Ventriculomegaly Wistar Rat Brains: A Pathological Correlation Study of Diffusion Tensor and Magnetization Transfer Imaging in Mild Traumatic Brain Injury.

Authors:  Tsang-Wei Tu; Jacob D Lescher; Rashida A Williams; Neekita Jikaria; L Christine Turtzo; Joseph A Frank
Journal:  J Neurotrauma       Date:  2016-04-11       Impact factor: 5.269

2.  Phenotype, biochemical features, genotype and treatment outcome of pyridoxine-dependent epilepsy.

Authors:  Amal Al Teneiji; Theodora U J Bruun; Dawn Cordeiro; Jaina Patel; Michal Inbar-Feigenberg; Shelly Weiss; Eduard Struys; Saadet Mercimek-Mahmutoglu
Journal:  Metab Brain Dis       Date:  2016-11-23       Impact factor: 3.584

3.  Imaging of spontaneous ventriculomegaly and vascular malformations in Wistar rats: implications for preclinical research.

Authors:  Tsang-Wei Tu; L Christine Turtzo; Rashida A Williams; Jacob D Lescher; Dana D Dean; Joseph A Frank
Journal:  J Neuropathol Exp Neurol       Date:  2014-12       Impact factor: 3.685

Review 4.  Treatable Genetic Metabolic Epilepsies.

Authors:  Lama Assi; Youssef Saklawi; Pascale E Karam; Makram Obeid
Journal:  Curr Treat Options Neurol       Date:  2017-09       Impact factor: 3.598

5.  Lysine-restricted diet and mild cerebral serotonin deficiency in a patient with pyridoxine-dependent epilepsy caused by ALDH7A1 genetic defect.

Authors:  Saadet Mercimek-Mahmutoglu; Dawn Corderio; Laura Nagy; Carly Mutch; Melissa Carter; Eduard Struys; Lianna Kyriakopoulou
Journal:  Mol Genet Metab Rep       Date:  2014-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.